Reinitiating lung development: a novel approach in the management of bronchopulmonary dysplasia
Abstract Bronchopulmonary dysplasia (BPD) is the predominant chronic lung disease in preterm infants, linked with various adverse long-term outcomes. Multiple prenatal and postnatal risk factors can impede lung development, leading to BPD. Current management of BPD relies heavily on pharmacotherapie...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-10-01
|
| Series: | Respiratory Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12931-024-02996-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850201844603682816 |
|---|---|
| author | Xuewei Cui Jianhua Fu |
| author_facet | Xuewei Cui Jianhua Fu |
| author_sort | Xuewei Cui |
| collection | DOAJ |
| description | Abstract Bronchopulmonary dysplasia (BPD) is the predominant chronic lung disease in preterm infants, linked with various adverse long-term outcomes. Multiple prenatal and postnatal risk factors can impede lung development, leading to BPD. Current management of BPD relies heavily on pharmacotherapies and alterations in ventilatory strategies. However, these interventions only mitigate BPD symptoms without addressing underlying alveolar, vascular, structural, and functional deficiencies. Given the retarded lung development in infants with BPD and the limitations of existing modalities, new therapeutic approaches are imperative. The induced differentiation of stem/progenitor cells and the spatiotemporal expression patterns of growth factors associated with lung developmental processes are critical for lung development reactivation in BPD, which focuses on stimulating pulmonary vasculogenesis and alveolarization. This review summarizes the process of lung development and offers a comprehensive overview of advancements in therapies designed to reinitiate lung development in BPD. Furthermore, we assessed the potential of these therapies for maintaining lung homeostasis and effectively restoring pulmonary structure and function through stem/progenitor cells and growth factors, which have been widely researched. |
| format | Article |
| id | doaj-art-aab42bb55fc3408fa918700eec9d9b73 |
| institution | OA Journals |
| issn | 1465-993X |
| language | English |
| publishDate | 2024-10-01 |
| publisher | BMC |
| record_format | Article |
| series | Respiratory Research |
| spelling | doaj-art-aab42bb55fc3408fa918700eec9d9b732025-08-20T02:11:55ZengBMCRespiratory Research1465-993X2024-10-0125111510.1186/s12931-024-02996-8Reinitiating lung development: a novel approach in the management of bronchopulmonary dysplasiaXuewei Cui0Jianhua Fu1Department of Pediatrics, Shengjing Hospital of China Medical UniversityDepartment of Pediatrics, Shengjing Hospital of China Medical UniversityAbstract Bronchopulmonary dysplasia (BPD) is the predominant chronic lung disease in preterm infants, linked with various adverse long-term outcomes. Multiple prenatal and postnatal risk factors can impede lung development, leading to BPD. Current management of BPD relies heavily on pharmacotherapies and alterations in ventilatory strategies. However, these interventions only mitigate BPD symptoms without addressing underlying alveolar, vascular, structural, and functional deficiencies. Given the retarded lung development in infants with BPD and the limitations of existing modalities, new therapeutic approaches are imperative. The induced differentiation of stem/progenitor cells and the spatiotemporal expression patterns of growth factors associated with lung developmental processes are critical for lung development reactivation in BPD, which focuses on stimulating pulmonary vasculogenesis and alveolarization. This review summarizes the process of lung development and offers a comprehensive overview of advancements in therapies designed to reinitiate lung development in BPD. Furthermore, we assessed the potential of these therapies for maintaining lung homeostasis and effectively restoring pulmonary structure and function through stem/progenitor cells and growth factors, which have been widely researched.https://doi.org/10.1186/s12931-024-02996-8Reinitiate lung developmentStem/progenitor cellGrowth factorBronchopulmonary dysplasiaPreterm infants |
| spellingShingle | Xuewei Cui Jianhua Fu Reinitiating lung development: a novel approach in the management of bronchopulmonary dysplasia Respiratory Research Reinitiate lung development Stem/progenitor cell Growth factor Bronchopulmonary dysplasia Preterm infants |
| title | Reinitiating lung development: a novel approach in the management of bronchopulmonary dysplasia |
| title_full | Reinitiating lung development: a novel approach in the management of bronchopulmonary dysplasia |
| title_fullStr | Reinitiating lung development: a novel approach in the management of bronchopulmonary dysplasia |
| title_full_unstemmed | Reinitiating lung development: a novel approach in the management of bronchopulmonary dysplasia |
| title_short | Reinitiating lung development: a novel approach in the management of bronchopulmonary dysplasia |
| title_sort | reinitiating lung development a novel approach in the management of bronchopulmonary dysplasia |
| topic | Reinitiate lung development Stem/progenitor cell Growth factor Bronchopulmonary dysplasia Preterm infants |
| url | https://doi.org/10.1186/s12931-024-02996-8 |
| work_keys_str_mv | AT xueweicui reinitiatinglungdevelopmentanovelapproachinthemanagementofbronchopulmonarydysplasia AT jianhuafu reinitiatinglungdevelopmentanovelapproachinthemanagementofbronchopulmonarydysplasia |